Literature DB >> 20173519

C1 lateral mass fixation: a comparison of constructs.

Praveen V Mummaneni1, Daniel C Lu, Sanjay S Dhall, Valli P Mummaneni, Dean Chou.   

Abstract

OBJECTIVE: We review our experience and technique for C1 lateral mass screw fixation. We compare the results of 3 different constructs incorporating C1 lateral mass screws: occipitocervical (OC) constructs, C1-C2 constructs, and C1 to mid/low cervical constructs.
METHODS: We performed a retrospective chart review of 42 consecutive patients who underwent C1 lateral mass fixation by 2 of the authors (PVM and DC). The patient population consisted of 24 men and 18 women with a mean age of 64 years. Twenty-two patients had C1-C2 constructs. Twelve patients had constructs that started at C1 and extended to the mid/low cervical spine (one extended to T1). Eight patients underwent OC fusions incorporating C1 screws (2 of which were OC-thoracic constructs). All constructs were combined either with a C2 pars screw (38 patients), C2 translaminar screw (1 patient), or C3 lateral mass screw (3 patients). No C2 pedicle screws were used. Fusion was assessed using flexion-extension x-rays in all patients and computed tomographic scans in selected cases. Clinical outcomes were assessed with preoperative and postoperative visual analog scale neck pain scores and Nurick grading. The nuances of the surgical technique are reviewed, and a surgical video is included.
RESULTS: Two patients (5%) were lost to follow-up. The mean follow-up for the remaining patients was 2 years. During the follow-up period, there were 4 deaths (none of which were related to the surgery). For patients with follow-up, the visual analog scale neck pain score improved a mean of 3 points after surgery (P < .001). For patients with myelopathy, the Nurick score improved by a mean of 1 grade after surgery (P < .001). The postoperative complication rate was 12%. The complication rate was 38% in OC constructs, 17% in C1 to mid/low cervical constructs, and 0% for C1-C2 construct cases. Patients with OC constructs had the statistically highest rate of complications (P < .001). Patients with C1 to mid/low cervical constructs had more complications than those with C1-C2 constructs (P < .001). Of the 42 cases, there were 3 pseudoarthroses (1 in an OC case, 1 in a C1 to midcervical construct, and 1 in a C1-C2 construct). OC constructs had the highest risk of pseudoarthrosis (13%) (P < .001).
CONCLUSION: Patients treated with C1 lateral mass fixation constructs have a high fusion rate, reduced neck pain, and improved neurologic function. Constructs using C1 lateral mass screws do not need to incorporate C2 pedicle screws. Constructs incorporating C1 lateral mass screws are effective when combined with C2 pars screws, C2 translaminar screws, and C3 lateral mass screws. Constructs using C1 screws are associated with a higher complication rate and a higher pseudoarthrosis rate if extended cranially to the occiput or if extended caudally below C2.

Entities:  

Mesh:

Year:  2010        PMID: 20173519     DOI: 10.1227/01.NEU.0000365804.75511.E2

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

1.  Placement of C1 Pedicle Screws Using Minimal Exposure: Radiographic, Clinical, and Literature Validation.

Authors:  Richard P Menger; Christopher M Storey; Menarvia K C Nixon; Justin Haydel; Anil Nanda; Anthony Sin
Journal:  Int J Spine Surg       Date:  2015-08-12

2.  Modified technique for C1-2 screw-rod fixation and fusion using autogenous bicortical iliac crest graft.

Authors:  Bin Ni; Fengjin Zhou; Qunfeng Guo; Songkai Li; Xiang Guo; Ning Xie
Journal:  Eur Spine J       Date:  2011-08-08       Impact factor: 3.134

3.  To the occiput or not? C1-c2 ligamentous laxity in children with down syndrome.

Authors:  Kris Siemionow; Dean Chou
Journal:  Evid Based Spine Care J       Date:  2014-10

4.  Atlas instrumentation guided by the medial edge of the posterior arch: An anatomic and radiologic study.

Authors:  Amro F Al-Habib; Abdulkarim Al-Rabie; Sami Aleissa; Abdulrahman Albakr; Abdulaziz Abobotain
Journal:  J Craniovertebr Junction Spine       Date:  2017 Apr-Jun

5.  Clinical application of the C2 pars screw technique in the treatment of ossification of the posterior longitudinal ligament.

Authors:  Zheng Wang; Heng-Rui Chang; Zhen Liu; Zhi-Wei Wang; Wen-Yuan Ding; Da-Long Yang
Journal:  BMC Musculoskelet Disord       Date:  2022-02-24       Impact factor: 2.362

6.  Biomechanical impact of C2 pedicle screw length in an atlantoaxial fusion construct.

Authors:  Risheng Xu; Mohamad Bydon; Mohamad Macki; Stephen M Belkoff; Evan R Langdale; Kelly McGovern; Jean-Paul Wolinsky; Ziya L Gokalsan; Ali Bydon
Journal:  Surg Neurol Int       Date:  2014-08-28

7.  Percutaneous anterior C1/2 transarticular screw fixation: salvage of failed percutaneous odontoid screw fixation for odontoid fracture.

Authors:  Ai-Min Wu; Hai-Ming Jin; Zhong-Ke Lin; Yong-Long Chi; Xiang-Yang Wang
Journal:  J Orthop Surg Res       Date:  2017-09-29       Impact factor: 2.359

8.  Accuracy and safety of C2 pedicle or pars screw placement: a systematic review and meta-analysis.

Authors:  Parisa Azimi; Taravat Yazdanian; Edward C Benzel; Hossein Nayeb Aghaei; Shirzad Azhari; Sohrab Sadeghi; Ali Montazeri
Journal:  J Orthop Surg Res       Date:  2020-07-20       Impact factor: 2.359

9.  Quantitative Assessment of the Anatomical Footprint of the C1 Pedicle Relative to the Lateral Mass: A Guide for C1 Lateral Mass Fixation.

Authors:  Brian W Su; Alexander A Theologis; Robert H Byers; Adam L Shimer; Gregory D Schroeder; Alexander R Vaccaro; Bobby Tay
Journal:  Global Spine J       Date:  2017-12-10

10.  A Prospective, Single-Blinded, Bicentric Study, and Literature Review to Assess the Need of C2-Ganglion Preservation - SAVIOUR's Criteria.

Authors:  Suyash Singh; Arun Kumar Srivastava; Jayesh Sardhara; Kamlesh Singh Bhaisora; Kuntal Kanti Das; Anant Mehrotra; Awadhesh Kumar Jaiswal; Manas Kumar Panigrahi; Sanjay Behari
Journal:  Neurospine       Date:  2020-11-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.